Medicines for Malaria Venture, Geneva, Switzerland.
EMBO Mol Med. 2017 Feb;9(2):133-134. doi: 10.15252/emmm.201607295.
In the context of drug resistance, malaria is no exception. Even the latest artemisinins have started to lose their full efficacy in patients. Didier Leroy tells us about the strategies adopted by Medicines for Malaria Venture to reduce this terrible culprit. [Image: see text]
在耐药性方面，疟疾也不例外。即使是最新的青蒿素类药物，也开始在患者身上失去全部疗效。Didier Leroy 向我们介绍了疟疾药物开发联盟采取的策略，以减少这一可怕的罪魁祸首。[图片：见正文]
